Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors
Copyright © 2002 American Urological Association, Inc.®. Published by Elsevier Inc. All rights reserved..
Patients with recurrent superficial bladder tumors have been treated by vesical and intradermal administration of Bacillus Calmette-Guerin. The pattern of recurrence in 9 patients has been altered favorably. Although the findings are still preliminary they appear to hold promise of a new therapeutic approach to the treatment of a group of neoplasms for which effective therapy is still lacking.
| Errataetall: |
CommentIn: J Urol. 2017 Feb;197(2S):S144-S145. - PMID 28012769 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:197 |
|---|---|
| Enthalten in: |
The Journal of urology - 197(2017), 2S vom: 15. Feb., Seite S142-S145 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Morales, A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antineoplastic Agents, Immunological |
|---|
| Anmerkungen: |
Date Completed 18.03.2019 Date Revised 03.01.2021 published: Print-Electronic CommentIn: J Urol. 2017 Feb;197(2S):S144-S145. - PMID 28012769 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.juro.2016.10.101 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM26744673X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM26744673X | ||
| 003 | DE-627 | ||
| 005 | 20231224220711.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.juro.2016.10.101 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0891.xml |
| 035 | |a (DE-627)NLM26744673X | ||
| 035 | |a (NLM)28012770 | ||
| 035 | |a (PII)S0022-5347(16)31654-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Morales, A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.03.2019 | ||
| 500 | |a Date Revised 03.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: J Urol. 2017 Feb;197(2S):S144-S145. - PMID 28012769 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2002 American Urological Association, Inc.®. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Patients with recurrent superficial bladder tumors have been treated by vesical and intradermal administration of Bacillus Calmette-Guerin. The pattern of recurrence in 9 patients has been altered favorably. Although the findings are still preliminary they appear to hold promise of a new therapeutic approach to the treatment of a group of neoplasms for which effective therapy is still lacking | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antineoplastic Agents, Immunological |2 NLM | |
| 650 | 7 | |a BCG Vaccine |2 NLM | |
| 700 | 1 | |a Eidinger, D |e verfasserin |4 aut | |
| 700 | 1 | |a Bruce, A W |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of urology |d 1945 |g 197(2017), 2S vom: 15. Feb., Seite S142-S145 |w (DE-627)NLM000006890 |x 1527-3792 |7 nnns |
| 773 | 1 | 8 | |g volume:197 |g year:2017 |g number:2S |g day:15 |g month:02 |g pages:S142-S145 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.juro.2016.10.101 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 197 |j 2017 |e 2S |b 15 |c 02 |h S142-S145 | ||